Pgm1-KO 基因敲除小鼠

1. Balakrishnan, Bijina, Altassan, Ruqaiah, Budhraja, Rohit, Morava, Eva, Lai, Kent. 2023. AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG). In Translational research : the journal of laboratory and clinical medicine, 257, 1-14. doi:10.1016/j.trsl.2023.01.004. https://pubmed.ncbi.nlm.nih.gov/36709920/

2. Radenkovic, Silvia, Bleukx, Sofie, Engelhardt, Nicole, Edmondson, Andrew C, Morava, Eva. 2024. Coagulation abnormalities and vascular complications are common in PGM1-CDG. In Molecular genetics and metabolism, 142, 108530. doi:10.1016/j.ymgme.2024.108530. https://pubmed.ncbi.nlm.nih.gov/38968673/

3. Zheng, Zhewen, Zhang, Xue, Bai, Jian, Liu, Di, Zhou, Yunfeng. 2022. PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway. In Cancer cell international, 22, 201. doi:10.1186/s12935-022-02545-7. https://pubmed.ncbi.nlm.nih.gov/35614441/